Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial.
about
Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic TrialsBlockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's diseaseBehavioral effects of cocaine mediated by nitric oxide-GAPDH transcriptional signaling.Neuroprotective function of cellular prion protein in a mouse model of amyotrophic lateral sclerosis.Effects of aerobic exercise therapy and cognitive behavioural therapy on functioning and quality of life in amyotrophic lateral sclerosis: protocol of the FACTS-2-ALS trialStem cell technology for neurodegenerative diseases.TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosisTauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosisIdentification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort.Non-self-sufficiency as a primary outcome measure in ALS trials.Evaluation of treatment effects in Alzheimer's and other neurodegenerative diseases by MRI and MRSBiological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study.Limitations of sniff nasal pressure as an outcome measurement in amyotrophic lateral sclerosis patients in a clinical trial.Cross-cultural adaptation and validation of als Functional Rating Scale-Revised in Portuguese language.Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients.Cross-sectional and longitudinal correlations between disease progression and different health-related quality of life domains in persons with amyotrophic lateral sclerosis.Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis.Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: a retrospective observational study
P2860
Q27021917-DB2039F7-BBF2-45A9-A502-0E743C2C7175Q27334874-6C4ECECB-388D-4D9C-9B8A-30C058BA20ABQ30580057-DAA6F08A-D73B-405B-B26B-AF4081751EF4Q33703773-8FBC004F-6DB5-4CC9-BAC8-EDD776DE6A9CQ33932196-F07E04C3-B410-453F-A0BD-27F2562146DCQ35224202-5139B0AC-1DC2-4306-925F-4B40410F43B5Q37213414-4BCEAD38-E60D-40A2-B41B-BE3799A01E88Q37257418-8738AA52-DF60-47A2-A669-07619D785A08Q37312624-B719ED22-5B83-45CE-BBA4-74F7A65A804DQ39215223-D2B3F632-0E78-460C-9B08-E64BAB5A0F2FQ41888068-78105FAE-B56A-44D0-8604-81A78463DE66Q42668576-75B13863-6513-41A3-9534-D162307BD801Q47324018-882CC94C-131F-4B74-AC18-71B0377B82FDQ47399902-1978D99A-C27E-468D-B7C5-7CE9BF6DA4E6Q48023496-F615DFA6-124A-49B2-8108-5C4684323D29Q50881104-030AC5A4-0E40-443C-973D-60F6ED72CFE6Q53040216-318486B0-FC08-4369-93D3-FB42FFE31840Q58005566-828FE344-D8AC-431F-A834-2F3573BFD188
P2860
Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Amyotrophic lateral sclerosis: ...... implementing a clinical trial.
@ast
Amyotrophic lateral sclerosis: ...... implementing a clinical trial.
@en
type
label
Amyotrophic lateral sclerosis: ...... implementing a clinical trial.
@ast
Amyotrophic lateral sclerosis: ...... implementing a clinical trial.
@en
prefLabel
Amyotrophic lateral sclerosis: ...... implementing a clinical trial.
@ast
Amyotrophic lateral sclerosis: ...... implementing a clinical trial.
@en
P2093
P2860
P50
P1476
Amyotrophic lateral sclerosis: ...... implementing a clinical trial.
@en
P2093
Kunio Tashiro
Leonard Van Den Berg
Robert G Miller
Yasuo Iwasaki
P2860
P356
10.1080/14660820410020187
P577
2004-06-01T00:00:00Z